标题 |
Safety and Efficacy of Subcutaneous Ianalumab (VAY736) for up to 68 Weeks in Patients with Systemic Lupus Erythematosus: Results from Phase 2 Study
系统性红斑狼疮患者皮下注射Ianalumab(VAY736)长达68周的安全性和有效性:2期研究结果
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 |